Clinical Trial Update: Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating interactions between estradiol therapy for transgender women and HIV treatment has been terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ESTRADIOL (Estradiol)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV I Infection | Phase 2 | Status: TERMINATED | Results posted: 2026-04-08